Literature DB >> 35586434

Small Molecule Inhibitors of TET Dioxygenases: Bobcat339 Activity Is Mediated by Contaminating Copper(II).

Nicholas A Weirath1, Alexander K Hurben1, Christopher Chao1, Suresh S Pujari1, Tao Cheng2, Shujun Liu2, Natalia Y Tretyakova1.   

Abstract

Ten eleven translocation (TET) dioxygenases 1-3 are non-heme Fe(II) and α-ketoglutarate dependent enzymes that catalyze oxidation of 5-methylcytosine (5mC) in DNA to hydroxymethyl-C, formyl-C, and carboxy-C. This typically leads to gene activation and epigenetic remodeling. Most known inhibitors of TET are α-ketoglutarate mimics that may interfere with other α-ketoglutarate dependent enzymes. Recently, a novel cytosine-based inhibitor of TET, Bobcat339, was reported to have mid-μM inhibitory activity against TET1 and TET2. The molecule is now sold as a TET inhibitor by several vendors. We independently prepared Bobcat339 in our laboratory and observed that it had minimal inhibitory activity against human TET1 and TET2 via a quantitative LC-ESI-MS/MS assay. Furthermore, the inhibitory activity of commercial Bobcat339 preparations was directly correlated with Cu(II) content. We therefore conclude that Bobcat339 alone is not capable of inhibiting TET enzymes at the reported concentrations, and that its activity is enhanced by contaminating Cu(II).
© 2022 American Chemical Society.

Entities:  

Year:  2022        PMID: 35586434      PMCID: PMC9109264          DOI: 10.1021/acsmedchemlett.1c00677

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.632


  35 in total

Review 1.  Inhibition of 2-oxoglutarate dependent oxygenases.

Authors:  Nathan R Rose; Michael A McDonough; Oliver N F King; Akane Kawamura; Christopher J Schofield
Journal:  Chem Soc Rev       Date:  2011-03-10       Impact factor: 54.564

2.  Selective targeting of TET catalytic domain promotes somatic cell reprogramming.

Authors:  Anup Kumar Singh; Bo Zhao; Xiuhua Liu; Xin Wang; Hongzhi Li; Hanjun Qin; Xiwei Wu; Yuelong Ma; David Horne; Xiaochun Yu
Journal:  Proc Natl Acad Sci U S A       Date:  2020-02-05       Impact factor: 11.205

3.  Loss of 5-hydroxymethylcytosine is a frequent event in peripheral T-cell lymphomas.

Authors:  François Lemonnier; Elsa Poullot; Aurélie Dupuy; Lucile Couronné; Nadine Martin; Laurianne Scourzic; Virginie Fataccioli; Julie Bruneau; Rob A Cairns; Tak W Mak; Olivier A Bernard; Laurence de Leval; Philippe Gaulard
Journal:  Haematologica       Date:  2017-12-14       Impact factor: 9.941

4.  Deletion of Tet2 in mice leads to dysregulated hematopoietic stem cells and subsequent development of myeloid malignancies.

Authors:  Zhe Li; Xiaoqiang Cai; Chen-Leng Cai; Jiapeng Wang; Wenyong Zhang; Bruce E Petersen; Feng-Chun Yang; Mingjiang Xu
Journal:  Blood       Date:  2011-07-29       Impact factor: 22.113

5.  Tumor suppressor TET2 promotes cancer immunity and immunotherapy efficacy.

Authors:  Yan-Ping Xu; Lei Lv; Ying Liu; Matthew D Smith; Wen-Cai Li; Xian-Ming Tan; Meng Cheng; Zhijun Li; Michael Bovino; Jeffrey Aubé; Yue Xiong
Journal:  J Clin Invest       Date:  2019-07-16       Impact factor: 14.808

6.  Structural insight into substrate preference for TET-mediated oxidation.

Authors:  Lulu Hu; Junyan Lu; Jingdong Cheng; Qinhui Rao; Ze Li; Haifeng Hou; Zhiyong Lou; Lei Zhang; Wei Li; Wei Gong; Mengjie Liu; Chang Sun; Xiaotong Yin; Jie Li; Xiangshi Tan; Pengcheng Wang; Yinsheng Wang; Dong Fang; Qiang Cui; Pengyuan Yang; Chuan He; Hualiang Jiang; Cheng Luo; Yanhui Xu
Journal:  Nature       Date:  2015-10-28       Impact factor: 49.962

7.  TET1 promotes growth of T-cell acute lymphoblastic leukemia and can be antagonized via PARP inhibition.

Authors:  Shiva Bamezai; Deniz Demir; Alex Jose Pulikkottil; Fabio Ciccarone; Elena Fischbein; Amit Sinha; Chiara Borga; Geertruy Te Kronnie; Lüder-Hinrich Meyer; Fabian Mohr; Maria Götze; Paola Caiafa; Klaus-Michael Debatin; Konstanze Döhner; Hartmut Döhner; Irene González-Menéndez; Leticia Quintanilla-Fend; Tobias Herold; Irmela Jeremias; Michaela Feuring-Buske; Christian Buske; Vijay P S Rawat
Journal:  Leukemia       Date:  2020-05-15       Impact factor: 11.528

8.  TET Upregulation Leads to 5-Hydroxymethylation Enrichment in Hepatoblastoma.

Authors:  Maria Prates Rivas; Talita Ferreira Marques Aguiar; Gustavo Ribeiro Fernandes; Luiz Carlos Caires-Júnior; Ernesto Goulart; Kayque Alves Telles-Silva; Monica Cypriano; Silvia Regina Caminada de Toledo; Carla Rosenberg; Dirce Maria Carraro; Cecilia Maria Lima da Costa; Isabela Werneck da Cunha; Ana Cristina Victorino Krepischi
Journal:  Front Genet       Date:  2019-06-12       Impact factor: 4.599

9.  TET1-mediated DNA hydroxymethylation activates inhibitors of the Wnt/β-catenin signaling pathway to suppress EMT in pancreatic tumor cells.

Authors:  Jian Wu; Hongzhe Li; Minmin Shi; Youwei Zhu; Yang Ma; Yiming Zhong; Cheng Xiong; Hao Chen; Chenghong Peng
Journal:  J Exp Clin Cancer Res       Date:  2019-08-09

10.  Dual-action inhibitors of HIF prolyl hydroxylases that induce binding of a second iron ion.

Authors:  Kar Kheng Yeoh; Mun Chiang Chan; Armin Thalhammer; Marina Demetriades; Rasheduzzaman Chowdhury; Ya-Min Tian; Ineke Stolze; Luke A McNeill; Myung Kyu Lee; Esther C Y Woon; Mukram M Mackeen; Akane Kawamura; Peter J Ratcliffe; Jasmin Mecinović; Christopher J Schofield
Journal:  Org Biomol Chem       Date:  2012-11-15       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.